Cervical adenocarcinoma – role of primary prophylaxis

Tomasz Paszkowski; Tomasz Radomański

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

3/2008
vol. 7

Send email

Copy url:

abstract:

Cervical adenocarcinoma – role of primary prophylaxis

Tomasz Paszkowski

,

Tomasz Radomański

Przegląd Menopauzalny 2008; 3: 144–147

Online publish date: 2008/07/07

View full text Get citation

In contrast to planoepithelial cervical carcinoma, the incidence of cervical adenocarcinoma is increasing, especially in young women. The efficacy of routinely used screening methods in detecting glandular precancerous lesions is significantly poorer than for planoepithelial ones. Infection with oncogenic types of human papillomavirus (HPV) constitutes the most important risk factor for the development of cervical adenocarcinoma. The three most frequent HPV types (16, 18 and 45) coexist with 93% of cases of cervical adenocarcinoma. The estimated protective potential of anti-HPV vaccination with regard to adenocarcinoma exceeds by approximately 20% the corresponding value regarding planoepithelial cervical cancer. The implementation of anti-HPV vaccination in adolescents prior to their exposure to the virus might prevent a significant number of cases of cervical adenocarcinoma.

keywords:

Cervical adenocarcinoma – role of primary prophylaxis

Tomasz Paszkowski , Tomasz Radomański

cervical adenocarcinoma, human papillomavirus, primary prophylaxis, vaccination

Tomasz Paszkowski

,

Tomasz Radomański